nirsevimab-alip
BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent Respiratory Syncytial Virus (RSV) disease for 5 months Indicated for newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.
